Instrument Inactif

Communiqués Allos Therapeutics, Inc.

Actions

US0197771019

Recherche biotechnologique et médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

05/09/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Expiration of Offering Period and Final Completion of Tender Offer for Shares of Allos Therapeutics	BU
29/08/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce That FTC Clears Transaction; Tender Offer for Shares of Allos Common Stock To Expire at 5pm Eastern Time on September 4, 2012	BU
17/08/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	BU
04/08/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	BU
20/07/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	BU
07/07/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	BU
22/06/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	BU
08/06/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	BU
25/05/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	BU
10/05/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Extension of Previously Announced Tender Offer For Shares of Allos Therapeutics	BU
02/05/12	Allos Therapeutics, Inc. : Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Allos Therapeutics, Inc.	BU
20/04/12	Allos Therapeutics, Inc. : Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN(R) in Europe	PU
20/04/12	Allos Therapeutics, Inc. : Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN® in Europe	BU
16/04/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos Therapeutics	BU
05/04/12	Allos Therapeutics, Inc. : (ALTH) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition By Spectrum Pharmaceuticals	PR
05/04/12	Allos Therapeutics, Inc. : Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012	BU
06/03/12	Allos Therapeutics, Inc. : Allos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results	BU
21/02/12	Allos Therapeutics, Inc. : Allos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012	BU
30/01/12	Allos Therapeutics, Inc. : Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN(R) and Bexarotene Demonstrate Activity in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma	PU
30/01/12	Allos Therapeutics, Inc. : Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN(R) in PTCL at the European Medicines Agency	PU
30/01/12	Allos Therapeutics, Inc. : Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines Agency	BU
30/01/12	Allos Therapeutics, Inc. : Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® and Bexarotene Demonstrate Activity in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma	BU
20/01/12	Allos Therapeutics, Inc. : Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN	BU
10/01/12	Allos Therapeutics, Inc. : Allos Therapeutics Reports 2011 Financial Highlights and Key Business Priorities	PU
10/01/12	Allos Therapeutics, Inc. : Allos Therapeutics Reports 2011 Financial Highlights and Key Business Priorities	BU